Click here to learn about Academy events, publications and initiatives around COVID-19.

We are experiencing intermittent technical difficulties. At this time, you may not be able to log in, register for an event, or make a donation via the website. We appreciate your patience, and apologize for any inconvenience this may cause.

Support The World's Smartest Network
×

Help the New York Academy of Sciences bring late-breaking scientific information about the COVID-19 pandemic to global audiences. Please make a tax-deductible gift today.

DONATE
This site uses cookies.
Learn more.

×

This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

We encourage you to learn more about cookies on our site in our Privacy policy and Terms of Use.

eBriefing

New Frontiers in CRISPR

CRISPR: New Frontiers
Reported by
Jordana Thibado

Posted April 20, 2020

Jordana Thibado is a New York City-based biophysics PhD candidate and science writer.

Presented By

CRISPR Discussion Group

The New York Academy of Sciences

The use of CRISPR-Cas systems for genome editing has dramatically transformed the biomedical research landscape since its discovery in prokaryotic adaptive immunity. The subsequent development of CRISPR-based tools has both improved our understanding of basic biology and enabled critical advancements in human health. Recent work harnessing these diverse and rapidly growing systems to target and modify specific RNA and DNA sequences has enabled a multitude of applications, such as genome editing, transcriptional modulation, forward genetic screens, lineage tracing, and more. However, many questions remain surrounding the full potential of CRISPR-Cas systems. Learn about the latest advances in CRISPR research in this summary of our February 24, 2020 symposium.

Symposium Highlights

  • CRISPR-Cas immunization requires dead phage DNA. >
  • RNA-guided integration of mobile genetic elements uses CRISPR without introducing double-stranded DNA breaks. >
  • Chromatin is often excluded from nuclear bodies in the cell, unlike dominant thinking that chromatin is pulled into nuclear condensates during transcription. >
  • A novel pooled genetic screen revealed a new Cas9 variant that has improved gene activation at a variety of target sites. >
  • Perturb-seq, which combines single-cell RNA sequencing with CRISPR-induced genetic perturbations, uncovers gene pairs that induce phenotypes like cell differentiation. >
  • CRISPR perturbation of schizophrenia-related genes shows that genes modulated in concert, but not individually, mimic postmortem brain analyses of schizophrenic patients. >
  • In vivo CRISPR screening has identified new cancer immunotherapy targets. >
  • Combining large-scale human RNA sequencing datasets with experimental validation has enabled the discovery of an autoimmune disease-associated locus. >
Uncovering Mechanisms of CRISPR-Cas Systems
Expanding the Genome Engineering Toolbox
Harnessing Big Data for Human Genome Insight